RNA interference therapies could be on the cusp of success This new way of modifying problematic gene expression has had a rocky start — but things are looking up.…
Blocking the immune system in rheumatoid arthritis Rheumatoid arthritis is caused by the immune system attacking the body. It afflicts about 1% of people in the UK and is now treated with a variety of biologic drugs that dampen the immune system in different ways…
FDA approves two new drugs for irritable bowel syndrome The US Food and Drug Administration has approved two new treatments for patients with irritable bowel syndrome with diarrhoea.…
Broadly neutralising antibody shows some success in treating patients with HIV A potent type of antibody therapy trialled in HIV patients for the first time has been shown to reduce the amount of virus in patients’ blood.…
Major bleeding risk higher for dabigatran than for warfarin, study suggests Research suggests that dabigatran is associated with a higher risk of bleeding compared with warfarin in a US population sample.…
Genes influence response to statins, research finds Four genes are responsible for about 5% of the variation in an individual’s response to statin treatment, research suggests.…
